antisense oligonucleotide (Idera/GSK)

N/A

Report date: 2025/03/14 16:18:56
NME

Base Information

Drug Nameantisense oligonucleotide (Idera/GSK)
Drug Alias Name3GA renal disease program (Idera/GlaxoSmithKline)antisense oligonucleotide (Idera/GlaxoSmithKline)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAceragen IncGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A